Icosavax (ICVX) News Today → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free ICVX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 21, 2024 | morningstar.comNervGen Pharma Corp Ordinary Shares NGENMarch 20, 2024 | markets.businessinsider.comCHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)February 19, 2024 | marketbeat.comTrading was temporarily halted for "ICVX" at 07:02 PM with a stated reason of "News pending."February 17, 2024 | marketbeat.comIcosavax, Inc. (NASDAQ:ICVX) Shares Bought by Barclays PLCBarclays PLC grew its holdings in Icosavax, Inc. (NASDAQ:ICVX - Free Report) by 3,589.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 202,182 shares of the company's stock after purchasing an additional 196,702 shareFebruary 11, 2024 | seekingalpha.comIcosavax: Tender Offer With Contingent Value RightFebruary 2, 2024 | marketbeat.comIcosavax, Inc. (NASDAQ:ICVX) CEO Sells $229,350.00 in StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) CEO Adam K. Simpson sold 15,000 shares of the company's stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $15.29, for a total transaction of $229,350.00. Following the transaction, the chief executive officer now directly owns 358,657 shares of the company's stock, valued at approximately $5,483,865.53. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.January 5, 2024 | seekingalpha.comIcosavax CVR Seems Fairly ValuedJanuary 4, 2024 | marketbeat.comAdam K. Simpson Sells 15,000 Shares of Icosavax, Inc. (NASDAQ:ICVX) StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) CEO Adam K. Simpson sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $15.67, for a total transaction of $235,050.00. Following the completion of the sale, the chief executive officer now directly owns 260,641 shares of the company's stock, valued at approximately $4,084,244.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.January 2, 2024 | msn.comGuggenheim Downgrades Icosavax (ICVX)January 2, 2024 | marketbeat.comIcosavax's (ICVX) "Neutral" Rating Reiterated at GuggenheimGuggenheim reissued a "neutral" rating on shares of Icosavax in a research note on Tuesday.December 31, 2023 | businesswire.comICOSAVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Icosavax, Inc. - ICVXDecember 24, 2023 | finance.yahoo.comChief Medical Officer Niranjan Kanesa-thasan Sells 11,884 Shares of Icosavax Inc (ICVX)December 22, 2023 | marketbeat.comInsider Selling: Icosavax, Inc. (NASDAQ:ICVX) Insider Sells 11,884 Shares of StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) insider Niranjan Kanesa-Thasan sold 11,884 shares of the business's stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $15.46, for a total value of $183,726.64. Following the completion of the transaction, the insider now owns 223,980 shares of the company's stock, valued at $3,462,730.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 18, 2023 | ca.finance.yahoo.comICVX Jul 2024 15.000 callDecember 18, 2023 | marketbeat.comIcosavax, Inc. (NASDAQ:ICVX) Short Interest Down 5.6% in NovemberIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) saw a significant decrease in short interest in November. As of November 30th, there was short interest totalling 1,680,000 shares, a decrease of 5.6% from the November 15th total of 1,780,000 shares. Approximately 5.2% of the company's shares are sold short. Based on an average daily volume of 317,300 shares, the short-interest ratio is presently 5.3 days.December 16, 2023 | finance.yahoo.comInsider Sell Alert: Chief Business Officer Cassia Cearley Sells 8,759 Shares of Icosavax Inc (ICVX)December 15, 2023 | marketbeat.comCassia Cearley Sells 8,759 Shares of Icosavax, Inc. (NASDAQ:ICVX) StockIcosavax, Inc. (NASDAQ:ICVX - Get Free Report) insider Cassia Cearley sold 8,759 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $16.01, for a total value of $140,231.59. Following the sale, the insider now owns 131,200 shares of the company's stock, valued at $2,100,512. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.December 14, 2023 | marketbeat.comIcosavax (NASDAQ:ICVX) Downgraded by William BlairWilliam Blair cut shares of Icosavax from an "outperform" rating to a "market perform" rating in a research note on Tuesday.December 13, 2023 | finance.yahoo.comIcosavax, Inc. (ICVX) Is Up 0.10% in One Week: What You Should KnowDecember 13, 2023 | finance.yahoo.comIcosavax, Inc. (ICVX) Moves to Buy: Rationale Behind the UpgradeDecember 12, 2023 | realmoney.thestreet.comIcosavax just downgraded at Jefferies, here's whyDecember 12, 2023 | msn.comIcosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, CanadaDecember 12, 2023 | realmoney.thestreet.comIcosavax just downgraded at William Blair, here's whyDecember 12, 2023 | stockhouse.comShareholder Alert: Ademi LLP investigates whether Icosavax, Inc. has obtained a Fair Price in its transaction with AstraZenecaDecember 12, 2023 | tmcnet.comICVX STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Icosavax, Inc. Is Fair to ShareholdersDecember 12, 2023 | markets.businessinsider.comWhy Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketDecember 12, 2023 | msn.comAstraZeneca to acquire vaccine maker Icosavax in ~$1.1B dealDecember 12, 2023 | finance.yahoo.comIcosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older AdultsDecember 12, 2023 | finance.yahoo.comIcosavax, Inc. Announces Agreement to be Acquired by AstraZenecaDecember 8, 2023 | finance.yahoo.comWall Street Analysts Believe Icosavax, Inc. (ICVX) Could Rally 175.87%: Here's is How to TradeDecember 4, 2023 | finance.yahoo.comIcosavax, Inc. (ICVX) is on the Move, Here's Why the Trend Could be SustainableNovember 27, 2023 | msn.comIcosavax (ICVX) Price Target Increased by 5.00% to 24.99November 18, 2023 | msn.comGuggenheim Initiates Coverage of Icosavax (ICVX) with Buy RecommendationNovember 17, 2023 | realmoney.thestreet.comIcosavax initiated with a Buy at GuggenheimNovember 16, 2023 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on Icosavax (ICVX)November 15, 2023 | markets.businessinsider.comTarget Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On WednesdayNovember 15, 2023 | finanznachrichten.deIcosavax, Inc.: Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 14, 2023 | finance.yahoo.comIcosavax Inc (ICVX) Reports Q3 2023 Financial Results and Corporate ProgressNovember 14, 2023 | finance.yahoo.comIcosavax Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 10, 2023 | seekingalpha.comAura Biosciences GAAP EPS of -$0.48November 8, 2023 | finance.yahoo.comIcosavax to Participate in the Jefferies London Healthcare ConferenceOctober 31, 2023 | finance.yahoo.comIcosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) ConferenceOctober 30, 2023 | finance.yahoo.comWe're Not Very Worried About Icosavax's (NASDAQ:ICVX) Cash Burn RateSeptember 19, 2023 | finance.yahoo.comIcosavax to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023September 1, 2023 | marketbeat.comTower Research Capital LLC TRC Acquires 20,910 Shares of Icosavax, Inc. (NASDAQ:ICVX)Tower Research Capital LLC TRC increased its stake in shares of Icosavax, Inc. (NASDAQ:ICVX - Free Report) by 1,516.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,289 shares of the company's stock after acquiring aAugust 15, 2023 | markets.businessinsider.comJefferies Reaffirms Their Buy Rating on Icosavax (ICVX)August 14, 2023 | finance.yahoo.comIcosavax Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 8, 2023 | finance.yahoo.comIcosavax Reports Positive 12-Month Durability Data for VLP Vaccine Candidate IVX-121 Against RSV and Initial Evidence for Revaccination PotentialJuly 3, 2023 | marketbeat.comETF Managers Group LLC Takes Position in Icosavax, Inc. (NASDAQ:ICVX)ETF Managers Group LLC purchased a new stake in shares of Icosavax, Inc. (NASDAQ:ICVX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 12,961 shares of the company's stock, valued aJuly 2, 2023 | finance.yahoo.comIcosavax, Inc. (NASDAQ:ICVX) is largely controlled by institutional shareholders who own 53% of the company Get Icosavax News Delivered to You Automatically Sign up to receive the latest news and ratings for ICVX and its competitors with MarketBeat's FREE daily newsletter. Email Address My system predicted the BA collapse – now it’s issuing an AI warning (Ad)Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... ICVX Media Mentions By Week ICVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICVX News Sentiment▼0.000.57▲Average Medical News Sentiment ICVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICVX Articles This Week▼01▲ICVX Articles Average Week Get Icosavax News Delivered to You Automatically Sign up to receive the latest news and ratings for ICVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Pediatrix Medical Group News Y-mAbs Therapeutics News Sage Therapeutics News SIGA Technologies News Arcturus Therapeutics News Cogent Biosciences News PureTech Health News Longboard Pharmaceuticals News CARGO Therapeutics News Atrion News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICVX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperCrypto Millionaire Says: “Buy This $11 AI Coin.”InvestorPlaceThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icosavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
